Literature DB >> 32794215

Secukinumab promotes engagement of cholecystokinin and its receptor in epidermal keratinocytes of psoriasis patients.

Atsuko Funakoshi1, Toshiharu Fujiyama1, Kazuki Tatsuno1, Takatoshi Shimauchi1, Yoshiki Tokura1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32794215     DOI: 10.1111/1346-8138.15552

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  1 in total

1.  Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells.

Authors:  Atsuko Funakoshi; Tetsuya Honda; Taisuke Ito; Yoshiki Tokura
Journal:  JID Innov       Date:  2022-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.